Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marta Mosca

Showing results (291-300 of 377) with videos related to

Pageof 38
Sort By:
Annals of the Rheumatic Diseases|August 21, 2025
EULAR recommendations for a core dataset to support clinical care and translational and observational research in systemic lupus erythematosusJohanna Mucke, George Bertsias, Martin Aringer, et al.
Rheumatology (Oxford, England)|February 25, 2024
Therapeutic strategies and outcomes in neuropsychiatric systemic lupus erythematosus: an international multicentre retrospective studyAlessandra Bortoluzzi, Antonis Fanouriakis, Ettore Silvagni, et al.
Annals of the Rheumatic Diseases|October 17, 2024
Efficacy and safety of infliximab or adalimumab in severe mucocutaneous Behçet's syndrome refractory to traditional immunosuppressants: a 6-month, multicentre, randomised controlled, prospective, parallel group, single-blind trialRosaria Talarico, Nazzareno Italiano, Giacomo Emmi, et al.
Frontiers in Medicine|April 8, 2021
Neutrophil Extracellular Traps in the Autoimmunity ContextMaurizio Bruschi, Gabriella Moroni, Renato Alberto Sinico, et al.
RMD Open|February 8, 2019
IgG4-related diseases: state of the art on clinical practice guidelinesLuca Iaccarino, Rosaria Talarico, Carlo Alberto Scirè, et al.
Annals of the Rheumatic Diseases|May 17, 2019
EULAR recommendations for the management of antiphospholipid syndrome in adultsMaria G Tektonidou, Laura Andreoli, Marteen Limper, et al.
Lupus Science & Medicine|May 21, 2021
What are the topics you care about making trials in lupus more effective? Results of an Open Space meeting of international lupus expertsJohanna Mucke, Marta Alarcon-Riquelme, Jeanette Andersen, et al.
Frontiers in Medicine|October 13, 2022
An overlook on the current registries for rare and complex connective tissue diseases and the future scenario of TogethERN ReCONNETMatilde Bandeira, Federica Di Cianni, Diana Marinello, et al.
Journal of Autoimmunity|September 23, 2017
Clinical predictors of response and discontinuation of belimumab in patients with systemic lupus erythematosus in real life setting. Results of a large, multicentric, nationwide studyLuca Iaccarino, Laura Andreoli, Elena Bartoloni Bocci, et al.
Annals of the Rheumatic Diseases|May 30, 2024
Factors associated with disease flare following SARS-CoV-2 vaccination in people with inflammatory rheumatic and musculoskeletal diseases: results from the physician-reported EULAR Coronavirus Vaccine (COVAX) RegistryBayram Farisogullari, Saskia Lawson-Tovey, Kimme L Hyrich, et al.
Pageof 38

Showing results (291-300 of 377) with videos related to

Sort By:
Pageof 38
Annals of the Rheumatic Diseases|August 21, 2025
EULAR recommendations for a core dataset to support clinical care and translational and observational research in systemic lupus erythematosusJohanna Mucke, George Bertsias, Martin Aringer, et al.
Rheumatology (Oxford, England)|February 25, 2024
Therapeutic strategies and outcomes in neuropsychiatric systemic lupus erythematosus: an international multicentre retrospective studyAlessandra Bortoluzzi, Antonis Fanouriakis, Ettore Silvagni, et al.
Annals of the Rheumatic Diseases|October 17, 2024
Efficacy and safety of infliximab or adalimumab in severe mucocutaneous Behçet's syndrome refractory to traditional immunosuppressants: a 6-month, multicentre, randomised controlled, prospective, parallel group, single-blind trialRosaria Talarico, Nazzareno Italiano, Giacomo Emmi, et al.
Frontiers in Medicine|April 8, 2021
Neutrophil Extracellular Traps in the Autoimmunity ContextMaurizio Bruschi, Gabriella Moroni, Renato Alberto Sinico, et al.
RMD Open|February 8, 2019
IgG4-related diseases: state of the art on clinical practice guidelinesLuca Iaccarino, Rosaria Talarico, Carlo Alberto Scirè, et al.
Annals of the Rheumatic Diseases|May 17, 2019
EULAR recommendations for the management of antiphospholipid syndrome in adultsMaria G Tektonidou, Laura Andreoli, Marteen Limper, et al.
Lupus Science & Medicine|May 21, 2021
What are the topics you care about making trials in lupus more effective? Results of an Open Space meeting of international lupus expertsJohanna Mucke, Marta Alarcon-Riquelme, Jeanette Andersen, et al.
Frontiers in Medicine|October 13, 2022
An overlook on the current registries for rare and complex connective tissue diseases and the future scenario of TogethERN ReCONNETMatilde Bandeira, Federica Di Cianni, Diana Marinello, et al.
Journal of Autoimmunity|September 23, 2017
Clinical predictors of response and discontinuation of belimumab in patients with systemic lupus erythematosus in real life setting. Results of a large, multicentric, nationwide studyLuca Iaccarino, Laura Andreoli, Elena Bartoloni Bocci, et al.
Annals of the Rheumatic Diseases|May 30, 2024
Factors associated with disease flare following SARS-CoV-2 vaccination in people with inflammatory rheumatic and musculoskeletal diseases: results from the physician-reported EULAR Coronavirus Vaccine (COVAX) RegistryBayram Farisogullari, Saskia Lawson-Tovey, Kimme L Hyrich, et al.
Pageof 38